Moneycontrol
HomeNewsBusinessCompaniesWyeth's claim on Protonix unjustified: Sun Pharma
Trending Topics

Wyeth's claim on Protonix unjustified: Sun Pharma

“We strongly believe that we have reasons to disagree with the claim that they have made. Fundamentally, we also believe that the patent invalidated is something that we will continue to fight for, Uday Baldota, vice president - investor relations, Sun Pharma told CNBC-TV18.

February 16, 2012 / 15:15 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Wyeth Pharmaceuticals has filed a claim to seek USD 960 million in damages from Sun Pharmaceuticals  for alleged patent infringement in launching a generic version of Protonix in the United States. However, Sun Pharma disagrees with this claim and finds it unjustified.

first published: Feb 16, 2012 11:35 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!